64Cu-SAR-bisPSMA — catalyst calendar
Upcoming
| Date | Event | Company | Drug | Official source & verification |
|---|---|---|---|---|
| 2026-09 (month) in 26d
ESTIMATED |
READOUT
Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-ri
Phase 3 · Prostate Cancer, Prostatic Neoplasms |
Clarity Pharmaceuticals Ltd | 64Cu-SAR-bisPSMA |
ClinicalTrials.gov ↗
✓ Source-checked 2026-08-06
Sponsor-projected date — can change
|